Ren W, Fang Z, Dolzhenko E, et al. A Murine Database of Structural Variants Identifies A Candidate Gene for a Spontaneous Murine Lymphoma Model. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2026:e22890. doi:10.1002/advs.202522890
Publications
So J, Droznin AD, Tiwari P, et al. Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. International journal of radiation oncology, biology, physics. 2026. doi:10.1016/j.ijrobp.2025.12.043
Al-Eryani G, Van Der Leij S, Masle-Farquhar E, et al. Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response. Research square. 2026. doi:10.21203/rs.3.rs-8394722/v1
PMCID
PMC12803361
Kosmatka J, Liu C, Halpin JC, Lim D, Davis JH, Keating AE. A proteome-wide biochemical screen defines binding determinants of the core autophagy protein LC3B. bioRxiv : the preprint server for biology. 2026. doi:10.64898/2026.01.05.697675
PMCID
PMC12803145
Shi L, Giglio RM, Cai Q, et al. Mapping kinase-dependent tumor immune adaptation with multiplexed single-cell CRISPR screens. bioRxiv : the preprint server for biology. 2026. doi:10.64898/2026.01.08.698516
PMCID
PMC12803220
Bhate SS, Seigal A, Caicedo J. Deriving genetic codes for molecular phenotypes from first principles. bioRxiv : the preprint server for biology. 2026. doi:10.1101/2022.08.15.503769
PMCID
PMC12825100
Sun Y, Li S, Mitra B, Zhong L, Zhang A, Gewurz BE. Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway. PLoS pathogens. 2026;22(1):e1013898. doi:10.1371/journal.ppat.1013898
Merkin RD, Faden DL, Wirth LJ. Who Benefits and When? Applying Circulating Tumor Human Papillomavirus DNA for Human Papillomavirus-Associated Oropharyngeal Carcinoma. JCO oncology practice. 2026:OP2501201. doi:10.1200/OP-25-01201
Vassy JL, Dornisch AM, Karunamuni R, et al. Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study. Nature cancer. 2026. doi:10.1038/s43018-025-01103-0
Rodrigues PF, Wu S, Trsan T, et al. RORγt dendritic cells are a distinct lymphoid-derived lineage. Science immunology. 2026:eaed7439. doi:10.1126/sciimmunol.aed7439